Executive Summary
Byotrol is focused on the development, manufacture and sale of biocides for the control and elimination of micro organisms. Byotrol is a patented anti microbial technology which has been shown to safely control or eradicate the threats caused by micro-organisms, such as MRSA, e-coli and c-difficile.[1] Byotrol TM is now being actively marketed in both Europe and North America.
Company History
Current Events
Business Model
Products/Services
A six month study undertaken in 2006 at the Glasgow Royal Infirmary indicated that using wipes impregnated with Byotrol technology on around of 5% of high contact surfaces reduced the incidence of MRSA by up to 50%.
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
